Complexin Antibodies

Santa Cruz Biotechnology features a diverse variety of Complexin monoclonal antibodies for studying complexin proteins, which play a crucial role in synaptic transmission and neurotransmitter release. Complexin monoclonal antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Complexins are essential for the regulation of synaptic vesicle fusion and are involved in the modulation of neurotransmitter release, making them significant in understanding synaptic function and neurobiology. Research has shown that complexins play a vital role in maintaining proper synaptic function and neural communication. Understanding complexin behavior and regulation is crucial for developing treatments for various neurological conditions. Complexin proteins have been linked to several neurological disorders, including schizophrenia and autism spectrum disorders. Their role in synaptic plasticity highlights their importance in learning and memory processes. Ongoing research utilizing Santa Cruz Biotechnology monoclonal antibodies continues to advance our understanding of synaptic transmission and neurological disorders, contributing to potential therapeutic developments in neuroscience.